Montserrat Munoz Mateu

Articles by Montserrat Munoz Mateu

21 Distant Disease-Free Survival Across Key Subgroups From the Phase 3 NATALEE Trial of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Patients With HR+/HER2− Early Breast Cancer

BySara A. Hurvitz, MD,Michal Jarzab,Montserrat Munoz Mateu,Erin Cobain,Jin Zhang,Arielle Medford,Alistair Ring,Priyanka Sharma, MD,Christian Schem, MD,Ionut Temciuc,Zheng Li,Juan Pablo Zarate,Denise A. Yardley, MD

June 26th 2025

Latest Updated Articles

21 Distant Disease-Free Survival Across Key Subgroups From the Phase 3 NATALEE Trial of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Patients With HR+/HER2− Early Breast Cancer
June 26th 2025

Trending on CancerNetwork

Reading a Changed Eye Examination and Impact on Therapy

FDA Expands Approval for Nogapendekin Alfa in BCG-Unresponsive NMIBC

VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors

Operationalizing the First Dose and Building the Oncology and Eye Care Partnership

The Promise of CERVINO, MajesTEC-3, and EXCALIBER-RRMM in Multiple Myeloma